A sharp sell-off in the fag-end of the session engulfed markets on Tuesday as incidents of localised lockdowns increased in the country. The economically important state of Maharashtra tightened Covid-19-related curbs, allowing shops to stay open only between 7 AM and 11 AM, while eastern state of Jharkhand announced a complete lockdown for a week, starting Wednesday. Uttar Pradesh government has also announced weekend lockdown across the state. Given that India is grappling with a stronger second wave of Covid-19, Sameer Narang, chief economist at Bank of Baroda, believes that the government needs to announce a fresh stimulus package, tailor made for people and businesses impacted the most. He suggests that states can announce incentives for MSME investments to build supply chains under the Centre s PLI scheme. In addition to this, he says, RBI window of restructuring for MSMEs can be extended.
PM convinced Ja can manufacture vaccines, but
jamaicaobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamaicaobserver.com Daily Mail and Mail on Sunday newspapers.
PM convinced Ja can manufacture vaccines, but
jamaicaobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamaicaobserver.com Daily Mail and Mail on Sunday newspapers.
Sputnik V to be $300 million boost to Dr Reddy s
The company has got permission from the Drug Controller General of India (DCGI) to import the vaccine. Reddy s is also going to tap domestically contract manufactured vaccines as and when companies are allowed to start commercial manufacturing in India
PB Jayakumar | April 14, 2021 | Updated 17:35 IST
Dr Reddy s to market and distribute 250 doses of Sputnik V
Dr Reddy s Laboratories, which has exclusive marketing and distribution rights for the first 250 million doses of Russia s Sputnik V vaccines in India, may get potential upside revenues of $300 million from the contract, estimates an analyst report.
The government s Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recently recommended Russian Direct Investment Fund (RDIF) s Sputnik V vaccine for Emergency Use Authorisation (EUA) in India, subject to satisfactory immunogenicity data submission.
Sputnik V will be available in India in the current quarter, price discussions on: Dr Reddy s
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.